1. Home
  2. RDY vs CRS Comparison

RDY vs CRS Comparison

Compare RDY & CRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • CRS
  • Stock Information
  • Founded
  • RDY 1984
  • CRS 1910
  • Country
  • RDY India
  • CRS United States
  • Employees
  • RDY N/A
  • CRS N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • CRS Steel/Iron Ore
  • Sector
  • RDY Health Care
  • CRS Industrials
  • Exchange
  • RDY Nasdaq
  • CRS Nasdaq
  • Market Cap
  • RDY 11.6B
  • CRS 12.1B
  • IPO Year
  • RDY N/A
  • CRS N/A
  • Fundamental
  • Price
  • RDY $14.86
  • CRS $246.90
  • Analyst Decision
  • RDY Strong Buy
  • CRS Strong Buy
  • Analyst Count
  • RDY 2
  • CRS 2
  • Target Price
  • RDY $16.95
  • CRS $352.50
  • AVG Volume (30 Days)
  • RDY 1.1M
  • CRS 755.2K
  • Earning Date
  • RDY 10-24-2025
  • CRS 10-23-2025
  • Dividend Yield
  • RDY 0.48%
  • CRS 0.33%
  • EPS Growth
  • RDY 2.20
  • CRS 100.54
  • EPS
  • RDY 0.79
  • CRS 7.42
  • Revenue
  • RDY $3,897,394,052.00
  • CRS $2,877,100,000.00
  • Revenue This Year
  • RDY $7.33
  • CRS $10.28
  • Revenue Next Year
  • RDY $2.00
  • CRS $10.18
  • P/E Ratio
  • RDY $18.42
  • CRS $32.99
  • Revenue Growth
  • RDY 15.86
  • CRS 4.25
  • 52 Week Low
  • RDY $12.26
  • CRS $138.61
  • 52 Week High
  • RDY $16.17
  • CRS $290.84
  • Technical
  • Relative Strength Index (RSI)
  • RDY 63.75
  • CRS 51.83
  • Support Level
  • RDY $14.00
  • CRS $233.78
  • Resistance Level
  • RDY $14.48
  • CRS $247.92
  • Average True Range (ATR)
  • RDY 0.20
  • CRS 8.45
  • MACD
  • RDY 0.08
  • CRS -0.09
  • Stochastic Oscillator
  • RDY 91.02
  • CRS 40.36

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About CRS Carpenter Technology Corporation

Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.

Share on Social Networks: